Previous 10 | Next 10 |
home / stock / rhhvf / rhhvf news
2023-11-19 09:56:29 ET Summary WisdomTree International Quality Dividend Growth Fund selects ex-North America dividend stocks with quality and expected earnings growth characteristics. The fund is well-diversified across countries, sectors, and holdings, with a focus on Europe. ...
2023-11-16 12:35:07 ET Summary Recursion Pharmaceuticals, Inc. proof-of-concept data, from the phase 2 SYCAMORE study using REC-994 for the treatment of patients with Cerebral Cavernous Malformation, expected in the 2nd half of 2024. Safety and preliminary efficacy data, from the ...
2023-11-07 17:07:59 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-11-06 19:43:49 ET Summary Repare Therapeutics presented preliminary results from the phase 1 MYTHIC study using the lunresertib and camonsertib combination for the treatment of patients with multiple solid tumor types. The biotech plans to complete the phase 1 expansion porti...
2023-10-31 08:56:11 ET Summary Monte Rosa Therapeutics is making progress in developing molecular glue degraders to target undruggable diseases. The company has released preliminary PK/PD data for its MGD MRT-2359, showing promising results in MYC-driven solid tumors. Monte Ro...
2023-10-26 09:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A historically wide di...
2023-10-26 08:45:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A historically wide di...
2023-10-24 09:25:49 ET Summary Roche Holding AG acquires Telavant Holdings for $7.1B upfront and $150M milestone payment, potentially very interesting deal. Roivant Sciences owns a 75% equity interest in Telavant Holdings. Curiously, Roivant Sciences stock sold off on the news...
2023-10-23 03:10:38 ET More on Roche, Roivant Sciences Skin In The Game: Behind Roivant's Significant Rise Be Patient, Roche Is A Clear Buy At This Price Roche: Positive Readouts From Pipeline Roche: 2023 Should Mark The Bottom Roche slips after in-li...
2023-10-20 09:38:08 ET Summary Solid balance sheet, higher DPS expected, and firepower. Roche is a company to have. COVID-19 has positively impacted the company, and now Wall Street is discounting lower sales estimates. However, Roche is growing nicely. Despite a challenging e...
News, Short Squeeze, Breakout and More Instantly...
Roche Holding Div Rts Company Name:
RHHVF Stock Symbol:
OTCMKTS Market:
Roche Holding Div Rts Website:
Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care Canada NewsWire At the global HIMSS 1 Conference, Roche showcases navify Algorithm Suite, a single platform offering cli...
Roche Announces Brad Moore as President and CEO of Roche Diagnostics North America PR Newswire INDIANAPOLIS , Dec. 5, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Brad Moore as president and CEO of Roche Diagnost...